middl
east
respiratori
syndrom
coronaviru
merscov
betacoronaviru
infect
human
merscov
diseas
markedli
differ
human
coronavirus
includ
known
caus
mild
respiratori
infect
rather
merscov
infect
similar
sever
acut
respiratori
syndrom
coronaviru
sarscov
diseas
associ
acut
respiratori
distress
syndrom
addit
merscov
infect
result
kidney
failur
ultim
lead
death
octob
death
case
merscov
identifi
worldwid
case
fatal
rate
human
infect
merscov
typic
occur
countri
locat
middl
east
may
outbreak
report
south
korea
three
superspread
found
respons
major
infect
well
evid
tertiari
humantohuman
transmiss
urgent
need
develop
efficaci
vaccin
merscov
past
vaccin
strategi
viral
pathogen
compris
liveattenu
virus
passag
anim
host
cell
line
immun
howev
vaccin
alway
suffici
immunogen
safeti
concern
associ
use
liveattenu
vaccin
popul
particularli
young
old
pregnant
immunocompromis
inactiv
vaccin
safe
use
typic
induc
humour
immun
low
level
cellmedi
respons
report
inactiv
merscov
test
vaccin
inactiv
sarscov
vaccin
appear
littl
effect
mice
domest
ferret
recent
candid
vaccin
genet
engin
replicationdefici
avirul
use
therefor
elimin
concern
liveattenu
vaccin
could
revert
virul
recombin
merscov
lack
e
structur
protein
previous
develop
candid
vaccin
howev
protect
efficaci
yet
demonstr
merscov
candid
vaccin
current
develop
includ
spike
protein
nanoparticl
modifi
vaccinia
viru
vector
immunogen
base
fulllength
dna
subunit
protein
shown
abl
induc
neutral
antibodi
merscov
viruslik
particl
vlp
proteinonli
subunit
vaccin
emul
morpholog
nativ
viru
compar
inactiv
liveattenu
viru
vaccin
vlp
abl
induc
robust
humour
cellular
immun
respons
without
risk
revers
virul
furthermor
vlp
pathogen
gener
condit
studi
construct
recombin
baculoviru
coexpress
envelop
e
membran
gene
infect
cell
recombin
baculoviru
result
success
assembl
merscov
vlp
confirm
structur
integr
vlp
evalu
immunogen
merscov
vlp
vaccin
candid
rhesu
macaqu
merscov
e
gene
clone
modifi
pfastbacdu
vector
locat
shown
figur
recombin
plasmid
confirm
enzym
digest
analysi
well
dna
sequenc
recombin
plasmid
tranfect
cell
obtain
recombin
baculoviru
titer
recombin
baculoviru
stock
third
passag
determin
infecti
unit
ifu
ml
infect
cell
recombin
baculoviru
yield
merscov
vlp
purifi
discontinu
sucros
gradient
studi
immunofluoresc
assay
confirm
recombin
baculoviru
express
cell
result
immunofluoresc
studi
demonstr
express
three
structur
protein
figur
morpholog
merscov
vlp
investig
electron
microscopi
tem
diamet
merscov
vlp
approxim
nm
spike
readili
observ
around
spheric
particl
figur
ensur
incorpor
vlp
immunoelectron
microscopi
perform
goldtag
antibodi
rbd
result
show
gold
particl
appear
merscov
vlp
figur
demonstr
particl
contain
composit
merscov
vlp
confirm
western
blot
band
correspond
e
merscov
vlp
observ
figur
result
demonstr
merscov
vlp
autonom
assembl
insect
cell
infect
recombin
baculoviru
structur
similar
nativ
viru
next
object
answer
whether
express
insect
mammalian
cell
differ
glycosyl
level
protein
investig
transfect
bsr
cell
lysat
compar
purifi
merscov
vlp
western
blot
express
insect
cell
slightli
larger
produc
mammalian
cell
figur
evalu
humor
immun
respons
immun
nonhuman
primat
nhp
measur
serum
neutral
antibodi
merscov
live
viru
titer
determin
highest
serum
dilut
complet
prevent
cpe
least
well
virusneutr
antibodi
titer
fourth
immun
figur
also
measur
serum
igg
antibodi
concentr
rbd
protein
use
elisa
result
show
nhp
immun
vlp
alum
adjuv
abl
induc
consider
amount
igg
antibodi
endpoint
titer
measur
week
vaccin
figur
contrast
merscov
virusneutr
antibodi
rbdspecif
igg
detect
mockvaccin
nhp
assess
tcell
respons
nhp
follow
vaccin
extent
secret
pbmc
nhp
determin
use
elispot
assay
result
show
pbmc
vlpvaccin
nhp
significantli
higher
releas
upon
stimul
purifi
rbd
antigen
compar
pbmc
mockvaccin
anim
figur
contrast
secret
substanti
differ
two
group
figur
vlp
product
via
baculoviru
express
system
platform
insect
cell
tri
test
strategi
vaccin
develop
sever
vlpbase
prophylact
success
produc
test
commerci
includ
glaxosmithklin
vaccin
human
papillomaviru
hpv
thu
cervic
cancer
trival
hemagglutinin
vaccin
approv
fda
ingelvac
pcv
two
approv
anim
vaccin
porcin
circoviru
pcv
type
furthermor
varieti
influenza
vlp
also
demonstr
excel
immunogen
novavax
md
usa
produc
vlpbase
vaccin
target
influenza
viru
recent
shown
encourag
result
phase
ii
trial
past
find
show
sarscov
vlp
could
readili
assembl
coinfect
insect
cell
baculovirus
express
e
coexpress
e
singl
recombin
viru
allow
effici
assembl
releas
vlp
close
resembl
sarscov
size
particl
morpholog
also
viru
morphogenesi
howev
studi
coinfect
merscov
recombin
baculovirus
insect
cell
result
vlp
format
assess
tem
data
shown
rather
demonstr
vlp
consist
three
structur
envelop
protein
e
gener
insect
cell
similar
morpholog
merscov
virion
express
protein
insect
cell
slightli
larger
mammalian
cell
suggest
glycosyl
vlp
complet
knowledg
first
report
show
success
gener
merscov
vlp
consist
immunogen
protein
current
lack
anim
model
challeng
merscov
caus
uniform
lethal
nhp
develop
transient
infect
die
infect
wherea
transgen
mice
overexpress
die
merscov
infect
protect
efficaci
candid
vaccin
merscov
evalu
anim
stringent
condit
due
immunolog
similar
rhesu
macaqu
human
next
best
choic
determin
whether
merscov
vlp
abl
elicit
robust
level
immunogen
nhp
hope
human
react
vaccin
similar
manner
rational
support
past
studi
also
use
rhesu
macaqu
evalu
candid
countermeasur
merscov
infect
result
show
merscov
vlp
immunogen
abl
elicit
robust
level
specif
humour
cellmedi
immun
vaccin
nhp
immun
alum
adjuv
rhesu
macaqu
develop
virusneutr
antibodi
high
level
merscov
specif
igg
antibodi
rbd
vaccin
merscov
vlp
also
result
tcell
respons
rbd
assess
elispot
assay
peptidestimul
pbmc
secret
detect
pbmc
suggest
vlp
elicit
respons
sinc
specif
humor
immun
cell
immun
indispens
effect
vaccin
suggest
vlpbase
vaccin
potenti
protect
human
merscov
challeng
futur
experi
involv
efficaci
test
rhesu
macaqu
transgen
mice
overexpress
safeti
test
vlpbase
vaccin
candid
phase
clinic
trial
order
acquir
ternari
promot
transfer
plasmid
gene
segment
contain
termin
promot
sequenc
flank
sever
restrict
enzym
sequenc
synthes
modifi
sequenc
clone
bamhi
hindiii
site
pfastbacdu
vector
invitrogen
carlsbad
ca
control
polyhedron
promot
e
gene
sequenc
merscov
isol
obtain
ncbi
genbank
access
gene
codonoptim
best
possibl
express
level
insect
cell
biochem
synthes
sangon
biotech
china
fulllength
gene
encod
protein
insert
xhoi
kpni
site
control
promot
e
gene
clone
bamhi
ecori
site
control
polyhedron
promot
gene
insert
sali
noti
site
control
addit
promot
gener
recombin
plasmid
pfastbacdualsem
plasmid
examin
restrict
enzym
analysi
confirm
correct
orient
insert
bacmid
transfer
plasmid
express
sitespecif
transposit
e
gene
transform
ecoli
compet
cell
gener
recombin
bacmid
recombin
bacmid
authent
pcr
use
forward
revers
primer
transfect
insect
cell
use
liposom
follow
bactobac
express
system
manual
invitrogen
usa
supernat
contain
recombin
baculoviru
harvest
day
transfect
viral
stock
titer
baculoviru
stock
determin
use
rapid
titrat
kit
bacpakbaculoviru
rapid
titer
kit
clontech
usa
insect
cell
maintain
suspens
cultur
serumfre
medium
life
technolog
usa
agit
speed
rpm
merscov
vlp
produc
infect
cell
recombin
baculoviru
multipl
infect
moi
harvest
h
post
infect
hpi
suspens
first
centrifug
remov
cell
debri
supernat
ultracentrifug
g
h
obtain
vlp
pellet
purif
discontinu
sucros
gradient
band
sucros
repres
merscov
vlp
collect
immunofluoresc
assay
perform
previous
describ
briefli
cell
infect
recombin
baculoviru
h
fix
paraformaldehyd
minut
room
temperatur
subsequ
cell
incub
primari
antibodi
mous
polyclon
antibodi
merscov
e
protein
respect
contain
bovin
serum
albumin
h
three
wash
pb
contain
tween
pbst
secondari
antibodi
fitclabel
goat
mous
igg
evan
blue
ad
minut
room
temperatur
cell
observ
use
fluoresc
microscop
wash
merscov
vlp
load
onto
grid
kept
room
temperatur
min
stain
sodium
phosphotungst
examin
transmiss
electron
microscop
tem
immunoelectron
microscopi
iem
merscov
vlp
load
onto
formvarco
grid
remov
excess
sampl
solut
incub
mous
anti
antibodi
label
goldtag
goat
antimous
igg
antibodi
sigmaaldrich
saintloui
mo
usa
observ
tem
purifi
merscov
vlp
transfer
onto
polyvinyliden
fluorid
pvdf
membran
immobilinp
millipor
usa
sdspage
denatur
condit
western
blot
anti
e
mous
polyclon
antibodi
briefli
bsr
cell
transfect
cell
lyse
day
later
lysat
bsr
cell
merscov
vlp
cell
compar
use
anti
polyclon
sera
western
blot
six
rhesu
macaqu
random
two
group
one
group
vaccin
intramuscularli
im
gastrocnemiu
muscl
merscov
vlp
mix
alum
adjuv
thermo
usa
per
anim
group
given
equival
volum
pb
control
ident
vaccin
repeat
interv
three
time
group
blood
sampl
obtain
femor
vein
anim
prior
vaccin
rbdspecif
antibodi
sera
immun
control
monkey
measur
indirect
elisa
gene
encod
rbd
protein
spike
residu
merscov
amplifi
pcr
use
synthes
merscov
sequenc
genbank
access
templat
clone
express
vector
protein
purifi
ninta
affin
chromatograph
column
thermo
usa
accord
manufactur
instruct
briefli
microtit
plate
corn
costar
usa
precoat
purifi
rbd
antigen
concentr
dilut
moll
carbonatebicarbon
buffer
ph
incub
overnight
plate
block
h
serum
sampl
serial
dilut
ad
well
incub
h
three
wash
pbst
hrplabel
goat
polyclon
antibodi
monkey
igg
abcam
uk
ad
dilut
incub
h
wash
pbst
three
time
substrat
tmb
sigma
usa
ad
well
incub
min
stop
optic
densiti
valu
measur
use
elisa
plate
reader
wavelength
nm
biorad
usa
neutral
antibodi
titer
nhp
sera
detect
previous
describ
briefli
serial
dilut
serum
sampl
nhp
incub
viru
h
ad
monolay
vero
cell
triplic
viru
supernat
remov
h
cultur
replac
fresh
medium
cell
observ
daili
cytopath
effect
cpe
record
day
postinfect
highest
dilut
monkey
sera
complet
prevent
cpe
well
defin
viru
neutral
antibodi
lymphocyt
isol
peripher
blood
mononuclear
cell
pbmc
inocul
monkey
week
second
immun
plate
densiti
cell
per
well
elispot
plate
mabtech
ab
sweden
precoat
purifi
rbd
antigen
ad
final
concentr
stimul
cytokin
product
rest
assay
carri
accord
manufactur
instruct
spot
form
cell
sfc
count
use
autom
elispot
reader
aid
elispot
readerispot
aid
gmbh
ger
environ
hous
facil
rhesu
macaqu
accord
nation
standard
laboratori
anim
requir
china
gb
anim
studi
strictli
conduct
recommend
veterinari
institut
academi
militari
medic
scienc
approv
anim
welfar
ethic
committe
permit
number
